BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 306 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2024. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,486,502 | +23.1% | 13,792 | +8.4% | 0.01% | +25.0% |
Q1 2024 | $1,207,378 | -2.1% | 12,728 | -4.8% | 0.00% | -20.0% |
Q4 2023 | $1,233,157 | +103.7% | 13,369 | +10.9% | 0.01% | +66.7% |
Q3 2023 | $605,402 | -12.9% | 12,055 | +9.6% | 0.00% | 0.0% |
Q2 2023 | $695,390 | +61.3% | 11,003 | +14.8% | 0.00% | +50.0% |
Q1 2023 | $431,094 | +0.6% | 9,582 | -2.0% | 0.00% | 0.0% |
Q4 2022 | $428,462 | -15.0% | 9,780 | +27.9% | 0.00% | -33.3% |
Q3 2022 | $504,000 | +30.6% | 7,649 | 0.0% | 0.00% | +50.0% |
Q2 2022 | $386,000 | -23.6% | 7,649 | -3.2% | 0.00% | 0.0% |
Q1 2022 | $505,000 | -47.7% | 7,903 | -12.3% | 0.00% | -60.0% |
Q4 2021 | $965,000 | +45.6% | 9,010 | +39.7% | 0.01% | +25.0% |
Q3 2021 | $663,000 | +16.9% | 6,449 | -0.0% | 0.00% | +33.3% |
Q2 2021 | $567,000 | -9.3% | 6,451 | +0.3% | 0.00% | -25.0% |
Q1 2021 | $625,000 | -18.7% | 6,430 | -6.3% | 0.00% | -20.0% |
Q4 2020 | $769,000 | +48.5% | 6,860 | +22.9% | 0.01% | +25.0% |
Q3 2020 | $518,000 | +18.8% | 5,584 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $436,000 | +106.6% | 5,584 | +55.1% | 0.00% | +100.0% |
Q1 2020 | $211,000 | -9.4% | 3,600 | +23.9% | 0.00% | 0.0% |
Q4 2019 | $233,000 | +8.9% | 2,906 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $214,000 | -4.9% | 2,906 | +21.8% | 0.00% | 0.0% |
Q2 2019 | $225,000 | +17.8% | 2,385 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $191,000 | +21.7% | 2,385 | -18.0% | 0.00% | 0.0% |
Q4 2018 | $157,000 | -30.8% | 2,907 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $227,000 | +22.7% | 2,907 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $185,000 | -16.3% | 2,907 | +20.4% | 0.00% | 0.0% |
Q1 2018 | $221,000 | +56.7% | 2,415 | +29.4% | 0.00% | +100.0% |
Q4 2017 | $141,000 | +69.9% | 1,866 | +57.3% | 0.00% | 0.0% |
Q3 2017 | $83,000 | +38.3% | 1,186 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $60,000 | +50.0% | 1,186 | +18.8% | 0.00% | – |
Q1 2017 | $40,000 | – | 998 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |